Very Few OTC Launches ‘Excellent', Claims IQVIA Consumer Health

Most OTC product launches failed to live up to expectations, according to new research by IQVIA Consumer Health. IQVIA's Andy Tisman offers some principles for OTC firms to follow to achieve launch 'excellence'. 

Failed launch
• Source: Shutterstock

Less than 5% of global OTC product launches in key global consumer health markets can be considered “excellent,” according to recent research by IQVIA Consumer Health.

Based on peak market share and cumulative sales criteria, IQVIA Consumer Health’s research – led by IQVIA Consumer Health's global...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from International

More from Geography

AESGP Annual Meeting: Wastewater Directive Impact Assessment ‘Fundamentally Flawed’

 
• By 

AESGP president Jonathan Workman opens the 61st Annual Meeting with calls for industry unity in the face of the problematic revised EU Urban Wastewater Treatment Directive.

Over The Counter: Driving Innovation In France’s Self-Care Market, With NèreS’ Luc Besançon

 
• By 

HBW Insight speaks to NèreS' executive director Luc Besançon about the key issues facing France's self-care industry, especially Rx-to-OTC switch and the revised Urban Wastewater Treatment Directive.

‘We Must Have The Truth’ – Calls For UWWTD Review Intensify As Evidence Looks ‘Shaky’

 
• By 

The evidence underpinning the “polluter pays” principle of the revised Urban Wastewater Treatment Directive - which calls on Europe's pharmaceutical industry to cough up at least 80% of the cost of updating wastewater treatment facilities - is looking increasingly shaky, according to a new report.